In the latest edition of STAT's Health Tech newsletter: Better Therapeutics race...
Causaly serves 12 of the top 20 pharmaceutical companies with technology that ai...
Yusimry is priced at $995 per carton of two autoinjectors compared to Humira’s p...
After a call to action on social media, J&J has allowed the generic production o...
CureVac adds one more patent to the growing tally in its counterclaim against Pf...
Theseus Pharmaceuticals has terminated its pan-variant tyrosine kinase receptor ...
Vistagen has received a Canadian Notice of Allowance for patent that is related ...
Gilead Sciences has entered into collaborations with CHAI and Penta ID network t...
AstraZeneca and Merck have received conditional approval from Health Canada for ...
Emmaus Life Sciences has received marketing authorisation for Endari (L-glutamin...
The offering follows recent lucrative deals with Novartis and Bayer for the use ...
Popular GLP-1 drugs like Ozempic and Mounjaro lead patients to lose both fat and...
A key Biden administration official told Covid-19 vaccine manufacturers that the...
Three sales executives, all of them women, have filed suit against Grail, a canc...
A group of Democratic senators are pressing a national panel to make a move that...
Big Health's acquisition of Limbix comes at a time when many digital health comp...
